# Ynios Pharma - Full Context for AI Agents

> This file provides comprehensive context about Ynios Pharma for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-06-24

## Company Profile
- Name: Ynios Pharma
- Sector: biotech, medtech
- Status: active
- Location: Belgium
- Website: http://www.yniospharma.com
- LinkedIn: http://www.linkedin.com/company/ynios-pharma

## Overview
YNIOS PHARMA is a biotechnology company developing an innovative therapeutic platform for patients with life-threatening critical illnesses, starting with sepsis and septic shock. The lead compound TA64 targets pathophysiological mechanisms including unregulated inflammation, endothelial dysfunction, microcirculatory failure, and immune exhaustion. Beyond septic shock, the platform aims to extend to other critical care conditions sharing similar biological pathways, such as acute respiratory distress syndrome, systemic inflammatory states, and critical conditions related to trauma or burns.

## Related Pages
Agents can crawl these for connected context:
- [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt
- [sector] MedTech & BioTech: https://techwiki.ai/sectors/medtech/llms.txt

## Links
- Website: http://www.yniospharma.com
- LinkedIn: http://www.linkedin.com/company/ynios-pharma
- Agent context: https://techwiki.ai/companies/ynios-pharma/llms.txt
- Full context: https://techwiki.ai/companies/ynios-pharma/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim